2015
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015, 149: 223-237. PMID: 25982290, PMCID: PMC4755303, DOI: 10.1053/j.gastro.2015.05.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsFecal microbiota transplantationClostridium difficile infectionGut microbiotaRecurrent Clostridium difficile infectionInflammatory bowel diseaseIrritable bowel syndromeTreatment of patientsRobust safety dataLong-term safetyBowel diseaseBowel syndromeMetabolic syndromeMicrobiota transplantationDifficile infectionSafety dataTherapeutic efficacyOrgan systemsDisease statesHuman gutSyndromePossible roleDiseaseEfficacyMicrobiotaTreatment
1987
Protein-Losing Enteropathy in Acquired Immunodeficiency Syndrome due to Intestinal Kaposi's Sarcoma
Laine L, Politoske EJ, Gill P. Protein-Losing Enteropathy in Acquired Immunodeficiency Syndrome due to Intestinal Kaposi's Sarcoma. JAMA Internal Medicine 1987, 147: 1174-1175. PMID: 3592885, DOI: 10.1001/archinte.1987.00370060170028.Peer-Reviewed Original ResearchConceptsProtein-losing enteropathyIntestinal Kaposi's sarcomaKaposi's sarcomaImmunodeficiency syndromeFecal alpha-1-antitrypsinAcquired Immunodeficiency SyndromeAlpha-1 antitrypsinAnkle edemaPleural effusionMarked elevationGastrointestinal tractSarcomaEnteropathyPatientsHypoalbuminemiaAIDSSyndromeEdemaEffusionTractAntitrypsinMonths